Attenuation of skeletal muscle wasting with recombinant human growth hormone secreted from a tissue-engineered bioartificial muscle

Human Gene Therapy

Volumn 9, Issue 17, 1998, Pages 2555-2564

  Vandenburgh, Herman ^a,b,c   Del Tatto, Michael ^a   Shansky, Janet ^a   Goldstein, Lisa ^a   Russell, Kristina ^a   Genes, Nicholas ^c   Chromiak, Joseph ^a   Yamada, Shigeru ^d  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c Cell Based Delivery Inc   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; HUMAN GROWTH HORMONE; LIVER PROTEIN; RECOMBINANT GROWTH HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; GENETIC ENGINEERING; HINDLIMB; IMPLANT; MOUSE; MUSCLE ATROPHY; MYOBLAST; NONHUMAN; PLANTARIS MUSCLE; PROTEIN SYNTHESIS; SKELETAL MUSCLE; SLOW MUSCLE; SOLEUS MUSCLE; SUBCUTANEOUS TISSUE;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ANIMALS; ARTIFICIAL ORGANS; CELL LINE; CLONING, MOLECULAR; HUMAN GROWTH HORMONE; MALE; MICE; MICE, INBRED C3H; MUSCLE, SKELETAL; MUSCULAR ATROPHY; RECOMBINANT PROTEINS;

ANIMALIA; MURINAE;

EID: 0032553698     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349850019391     Document Type: Article

References (48)

1. AL-HENDY, A., HORTELANO, G., TANNENBAUM, G.S., and CHANG, P.L. (1995). Correction of the growth detect in dwarf mice with nonautologous myoblasts - an alternate approach to somatic gene therapy. Hum. Gene Ther. 6, 165-175.
2. ARONIADOU-ANDERJASKA, V., LEMON, P.W.R., and GILLOTEAUX, J. (1996). Effects of exogenous growth hormone on skeletal muscle of young female rats. Tissue Cell 28, 719-724.
3. BARR, E., and LEIDEN, J.M. (1991). Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507-1509.
4. BAUMANN, G. (1991). Growth hormone heterogeneity: Genes, isohormones, variants, and binding proteins. Endocr. Rev. 12, 424-449.
5. BEHARA, A.M., WESTCOTT, A.J., and CHANG, P.L. (1992). Intrathymic implants of genetically modified fibroblasts. FASEB J. 6, 2853-2858.
6. BLAU, H.M., and SPRINGER, M.L. (1995a). Gene therapy - a novel form of drug delivery. N. Engl. J. Med. 333, 1204-1207.
7. BLAU, H.M., and SPRINGER, M.L. (1995b). Muscle-mediated gene therapy. N. Engl. J. Med. 333, 1554-1556.
8. BONHAM, L., PALMER, T., and MILLER, A.D. (1996). Prolonged expression of therapeutic levels of human granulocyte colony-stimulating factor in rats following gene transfer to skeletal muscle. Hum. Gene Ther. 7, 1423-1429.
9. CARTER, W.J. (1996). Effect of anabolic hormones and insulin-like growth factor-I on muscle mass and strength in elderly persons. Clin. Ger. Med. 11, 735-748.
10. CHANG, P.L., SHEN, N., and WESTCOTT, A.J. (1993). Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4, 433-440.
11. CHO, M., WEBSTER, S.G., and BLAU, H.M. (1993). Evidence for myoblast-extrinsic regulation of slow myosin heavy chain expression during muscle fiber formation in embryonic development. J. Cell Biol. 121, 795-810.
12. CLARK, R.G., MORTENSEN, D.L., CARLSSON, L.M.S., CARLSSON, B., CARMIGNAC, D., and ROBINSON, I.C.A.F. (1996). The obese growth hormone (GH)-deficient dwarf rat: Body fat responses to patterned delivery of GH and insulin-like growth factor-I. Endocrinology 137, 1904-1912.
13. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. U.S.A. 89, 10892-10895.
14. DE BOER, H., BLOK, G.-J., and VAN DER VEEN, E.A. (1995). Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 16, 63-86.
15. DHAWAN, J., PAN, L.C., PAVLATH, G.K., TRAVIS, M.A., LANCTOT, A.M., and BLAU, H.M. (1991). Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512.
16. FANG, J., ZHU, Y.Y., SMILEY, E., BONADIO, J., ROULEAU, J., GOLDSTEIN, S.A., McCAULEY, L.K., DAVIDSON, B.L., and ROESSLER, B.J. (1996). Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. U.S.A. 93, 5753-5758.
17. GARGOSKY, S., TAPANAINEN, P., and ROSENFELD, R. (1994). Administration of growth hormone (GH) but not insulin-like factor-1 (IGF-1), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats. Endocrinology 134, 2267-2276.
18. GELATO, M.C. (1996). Aging and immune function: A possible role for growth hormone. Horm. Res. 45, 46-49.
19. GRINDELAND, R.E., ROY, R.R., EDGERTON, V.R., GROSSMAN, E.J., MUKKU, V.R., JIANG, B., PIEROTTI, D.J., and RUDOLPH, I. (1994). Interactive effects of growth hormone and exercise on muscle mass in suspended rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 267, R316-R322.
20. HAIDA, N., FOWLER, W.M., Jr., ABRESCH, R.T., LARSON, D.B., SHARMAN, R.B., TAYLOR, R.G., and ENTRIKIN, D.B. (1989). Effect of hind-limb suspension on young and adult skeletal muscle. I. Normal mice. Exp. Neurol. 103, 68-76.
21. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1994). Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA. Hum. Gene Ther. 5, 1349-1356.
22. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1995). Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95, 1808-1813.
23. HINTZ, R.L. (1996). Current and potential therapeutic uses of growth hormone and insulin-like growth factor I. Endocrinol. Metabol. Clin. North Am. 25, 759-773.
24. HUARD, J., ACSADI, G., JANI, A., MASSIE, B., and KARPATI, G. (1995). Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5, 949-958.
25. JOHNSON, O.L., CLELAND, J.L., LEE, H.J., CHARNIS, M., DUENAS, E., JAWOROWICZ, W., SHEPARD, D., SHAHZAMANI, A., JONES, A.J.S., and PUTNEY, S.D. (1996). A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 2, 795-799.
26. LANGER, R., and VACANTI, J.P. (1993). Tissue engineering. Science 260, 920-926.
27. LANGER, R., and VACANTI, J.P. (1995). Artificial organs. Sci. Am. 273, 130-133.
28. LINDERMAN, J.K., GOSSELINK, K.L., BOOTH, F.W., MUKKU, V.R., and GRINDELAND, R.E. (1994). Resistance exercise and growth hormone as countermeasures for skeletal muscle atrophy in hindlimb-suspended rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 267, R365-R371.
29. MA, J.-X., YANG, Z., CHAO, J., and CHAO, L. (1995). Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J. Biol. Chem. 270(1), 451-455.
30. MELING, T.R., and NYLEN, E.S. (1996). Growth hormone deficiency in adults: A review. Am. J. Med. Sci. 311, 153-166.
31. MOREY-HOLTON, E., and WRONSKI, J. (1981). Animal models for simulating weightlessness. Physiologist 24 (Suppl.), S45-S48.
32. MORGAN, J.R., BARRANDON, Y., GREEN, H., and MULLIGAN, R.C. (1986). Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237, 1476-1478.
33. NORSTEDT, G., and PALMITER, R. (1984). Secretory rhythm of growth hormone regulates sexual differentiation of muscle liver. Cell 36, 805-812.
34. PARK, E., and SCHULTZ, E. (1993). A simple hindlimb suspension apparatus. Aviat. Space Environ. Med. 64, 401-404.
35. PAVLATH, G.K., RANDO, T.A., and BLAU, H.M. (1994). Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J. Cell Biol. 127, 1923-1932.
36. ROY, R.R., TRI, C., GROSSMAN, E.J., TALMADE, R.J., GRINDELAND, R.E., MUKKU, V.R., and EDGERTON, V.R. (1996). IGF-1, growth hormone, and/or exercise effects on non-weight-bearing soleus of hypophysectomized rats. J. Appl. Physiol. 81, 302-311.
37. SCANES, C.G., and DAUGHADAY, W.H. (1995). Growth hormone action: Growth. In Growth Hormone. S. Harvey, C.G. Scanes, and W.H. Daughaday, eds. (CRC Press, Boca Raton, FL) pp. 351-369.
38. STROBL, J.S., and THOMAS, M.J. (1994). Human growth hormone. Pharmacol. Rev. 46, 1-34.
39. THOMPSON, J.L., BUTTERFIELD, G.E., MARCUS, R., HINTZ, R.L., VAN LOAN, M., GHIRON, L., and HOFFMAN, A.R. (1995). The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J. Clin. Endocrinol. Metab. 80, 1845-1852.
40. VANDENBURGH, H.H., SWASDISON, S., and KARLISCH, P. (1991). Computer aided mechanogenesis of skeletal muscle organs from single cells in vitro. FASEB J. 5, 2860-2867.
41. VANDENBURGH, H.H., DEL TATTO, M., SHANSKY, J., LEMAIRE, J., CHANG, A., PAYUMO, F., LEE, P., GOODYEAR, A., and RAVEN, L. (1996a). Tissue engineered skeletal muscle organoids for reversible gene therapy. Hum. Gene Ther. 7, 2195-2200.
42. VANDENBURGH, H.H., SOLERSSI, R., SHANSKY, J., ADAMS, J., and HENDERSON, S.A. (1996b). Mechanical stimulation of organogenic cardiomyocyte growth in vitro. Am. J. Physiol. (Cell Physiol. 39) 270, C1284-C1292.
43. VILE, R.G., and RUSSELL, S.J. (1995). Retroviruses as vectors. Br. Med. Bull. 51, 12-30.
44. WANG, X.M., ZINKEL, S., POLONSKY, K., and FUCHS, E. (1997). Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 94, 219-226.
45. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct new transfer into mouse muscle in vivo. Science 247, 1465-1468.
46. WRONSKI, T.J., and MOREY-HOLTON, E.R. (1987). Skeletal responses to simulated weightlessness: A comparison of suspension techniques. Aviat. Space Environ. Med. 58, 63-68.
47. XIONG, W., CHAO, J., and CHAO, L. (1995). Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension 25, 715-719.
48. YAO, S.-N., and KURACHI, K. (1992). Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. U.S.A. 89, 3357-3361.